Join Us | Booth 717
Entegris offerings include 2D and 3D bag assemblies, sterile filtration, and a U.S.-based Life Sciences Technology Center specializing in freeze/thaw. With a global footprint and local representation, we can guarantee a reliable and responsive supply chain that incorporates the latest research and best practices. We also provide more than just a large catalog. Talk to our experts and learn how we offer custom products and support backed by decades of experience, then discover how you can easily adapt Entegris’ life sciences solutions into your unique workflows.
Start-ups: our start-up village hosts early-stage companies for our audience to do business with early stage and mid stage biotech companies: a cross section of the developmental pipeline, buyers from every stage of development are present.
Networking: our networking app, Terrapinn Events App, facilitates networking for all attendees, creating a world-class environment for sponsors, speakers and guests alike.
With eight tracks of content, the agenda covers everything from manufacturing, supply chain and logistics, pricing and market access, to developments in key therapeutic areas; cell therapy, gene therapy, gene modified cell therapy, gene editing, stem cells, regenerative medicine, and much more.
Featured Presentation
From Bench to Business: Integrating Commercial Viability into Early Therapeutic Design
November 18 | 2:15 p.m.
As cell and gene therapies (CGTs) move toward commercialization, selecting the right ancillary materials (AMs) and single-use systems (SUS) is critical for ensuring product quality and process consistency.
This presentation introduces a practical, consensus-based framework developed by BioPhorum and industry experts to guide CGT manufacturers in making informed, application-specific material choices.
Drawing from global regulatory guidance and industry best practices, the framework incorporates risk-based assessments, critical material attributes, and Quality by Design principles. It offers tools and criteria for evaluating sterility, extractables/leachables, and performance in key applications like cryopreservation and fluid transfer. Ultimately, the framework supports scalable, compliant, and efficient CGT manufacturing.
Presenter:
Donnie Beers
Life Sciences Applications Leader, Cell and Gene Therapy, Entegris
Donnie has nearly 15 years’ experience working in single-use and automation technology in biopharma. Donnie joined Entegris in 2019 as Senior Product Manager for single-use products and has since taken a lead role in helping customers overcome unique challenges in cell and gene therapies. He has previously held roles in engineering management, project management, and manufacturing within a cGMP environment. Donnie earned his Bachelor of Science in biochemistry from the University of Wisconsin – Madison.
Event Related Content
Our Life Sciences Technology Center is your gateway to cutting-edge freeze/thaw technology and support. We provide everything needed to make educated decisions about what freezing process and products best fit your needs.
Entegris, a world-class supplier of advanced materials and process solutions for the semiconductor industry, brings over 50 years of contamination control expertise and supply chain strength to life sciences customers around the world. Our technologies help improve purity and yield in a wide range of pharmaceutical applications including COVID-19 vaccine manufacturing.
Aramus™ 2D single-use bags provide high purity, exceptional compatibility, and increased safety for critical process fluids and final products. These robust products are now available in custom shapes, sizes, and assembly configurations to optimize your process.
Many C> treatments such as CAR-T and mRNA vaccines require repeated freezing and thawing during production, storage, and delivery. Aramus™ single-use assemblies are ideal for protecting and optimizing the cold-chain freeze/thaw processes for these precious treatments.